Related Experiment Video
Updated: Jun 18, 2026
Transcriptional Analysis by Nascent RNA FISH of In Vivo Trophoblast Giant Cells or In Vitro Short-term Cultures of Ectoplacental Cone Explants
Published on: August 31, 2016
ERCC1 and XPF expression in human testicular germ cell tumors
Beate Köberle1, Walburgis Brenner, Andreas Albers
1Institute of Toxicology, University Medical Center Mainz, Mainz, Germany. koeberle@uni-mainz.de
Abstract:
Nucleotide excision repair (NER) is one of the factors influencing the cellular sensitivity to anticancer drugs. In the present study we compared the expression of the NER proteins ERCC1 and XPF in 24 testicular germ cell tumors (TGCT) with the corresponding normal testicular tissue of the same patient. Using immunoblotting, we demonstrated in TGCT a significant increase of ERCC1 expression compared to the normal tissue. There was no significant increase in XPF expression in TCGT. Based on histological characteristics TGCT are subgrouped into seminomas and non-seminomas, the latter being clinically more aggressive. Investigating ERCC1 levels in seminomas we found a slightly increased expression compared to normal tissue, which was, however, not significant. Similarly, no significant difference was observed for XPF levels in seminomas compared to normal testis tissue. In non-seminomas, however, we found a significant increase in the expression of ERCC1 (p<0.017) and XPF (p<0.03) when compared with the corresponding normal tissue. Comparing seminomas with non-seminomas, we observed a significant increase in the expression of ERCC1 (p<0.05) and XPF (p<0.007) in the non-seminomas. Furthermore, a correlation between the expression of ERCC1 and XPF was observed. Our data demonstrate that non-seminomas are characterized by an increased expression of ERCC1 and XPF protein compared to seminomas and the normal testis tissue. The data indicate a possible up-regulation of ERCC1 and XPF during TGCT progression.
Insights
Testicular germ cell tumors (TGCT) show altered expression of DNA repair proteins. Non-seminomas exhibit significantly higher levels of ERCC1 and XPF compared to seminomas and normal tissue, suggesting a role in tumor progression.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Nucleotide excision repair (NER) proteins influence cellular sensitivity to anticancer drugs.
- ERCC1 and XPF are key proteins in the NER pathway.
- Testicular germ cell tumors (TGCT) are a heterogeneous group of cancers.
Purpose of the Study:
- To compare the expression of ERCC1 and XPF proteins in TGCT and normal testicular tissue.
- To investigate differences in ERCC1 and XPF expression between seminomas and non-seminomas.
- To explore the correlation between ERCC1 and XPF expression in TGCT.
Main Methods:
- Immunoblotting was used to quantify ERCC1 and XPF protein levels.
- TGCT samples were compared with corresponding normal testicular tissue from the same patients.
- TGCT were sub-grouped into seminomas and non-seminomas for differential analysis.
Main Results:
- ERCC1 expression was significantly increased in TGCT compared to normal tissue.
- XPF expression showed no significant increase in TGCT overall.
- Non-seminomas displayed significantly higher ERCC1 and XPF expression compared to seminomas and normal tissue.
- A positive correlation was observed between ERCC1 and XPF expression.
Conclusions:
- Non-seminomas are characterized by elevated ERCC1 and XPF protein levels.
- Increased ERCC1 and XPF expression may be associated with TGCT progression.
- These findings suggest a potential role for NER pathway alterations in the clinical behavior of TGCT.
Related Concept Videos
02:32Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...